Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies’ CEO Devyn Smith, Ph.D., Elected as Chairman of the Alliance for Regenerative Medicine
October 20, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies to Participate in the 2022 Cell & Gene Meeting on the Mesa
October 04, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that senior...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
September 22, 2022 16:01 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Named One of Fierce Biotech’s “Fierce 15” Companies of 2022
September 12, 2022 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies today announced that Fierce Biotech has named it as one of 2022’s “Fierce 15” biotechnology companies, designating it as...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
September 01, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases
August 25, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has...
Arbor Biotechnologies Appoints Lee Ann Marchionna as Chief People Officer
August 02, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
July 20, 2021 08:00 ET
|
Arbor Biotechnologies Inc
- Pam Stetkiewicz, Ph.D., Appointed Chief Operating Officer - Kathryn McCabe, Ph.D., Named SVP, Head of Business Development CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Arbor...
Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
June 21, 2021 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...